Although we don't believe in timing the market or panicking over market movements, we do like to keep an eye on big changes -- just in case they're material to our investing thesis.
What: Shares of specialty chemicals maker Huntsman
So what: Huntsman's first-quarter beat was so wide -- adjusted EPS of $0.74 versus the consensus of just $0.40 -- that investors have no choice but to raise their growth estimates. In fact, revenue rose 9% to $2.91 billion on solid demand across several of its markets, suggesting that the macroeconomic winds are starting to turn in its favor.
Now what: Don't expect the operating momentum to wane anytime soon. "Notwithstanding certain economic challenges in various parts of the world, I am most optimistic about our earnings potential," CEO Peter Huntsman said in a statement. While buying into a double-digit rally isn't exactly ideal, Huntsman's still-paltry forward P/E leaves plenty of upside to work with.
Interested in more info on Huntsman? Add it to your watchlist.
